In the International Consensus Classification (ICC) of Mature Lymphoid Neoplasms published in 2022 (7), RDD and ALK-positive histiocytosis were regarded as distinct entities and gained autonomous recognition. The gene discussed is ALK; the disease is sinus histiocytosis with massive lymphadenopathy.